# Port-Site Metastasis After Laparoscopic Gastrectomy Extending to the Thigh: A Case Report

## TL;DR

A rare case of port-site metastasis after gastric cancer surgery led to severe pain and mobility issues, highlighting the need for early detection and treatment.

## Contribution

This case report documents the first known instance of port-site metastasis extending into the thigh muscle, causing significant functional decline.

## Key findings

- Port-site metastasis spread from the abdominal wall to the thigh, causing opioid-resistant pain and walking difficulties.
- Palliative radiotherapy failed to alleviate symptoms, leading to a decline in quality of life.
- Early detection and intervention may be critical for managing port-site metastasis and preserving patient function.

## Abstract

Port-site metastasis (PSM) is rare following laparoscopic gastrectomy for gastric cancer. Previous reports focused on localized lesions treated with excision; contrastingly, case reports describing extensive invasion into the lower extremity skeletal muscles causing deterioration in activities of daily living are nonexistent. A 55-year-old male underwent a laparoscopic distal gastrectomy for gastric cancer. The pathological findings revealed a stage IIIA tumor. Two years later, skin hardening was observed on the left upper abdominal wall. Computed tomography displayed a 13-cm-long, flat tumor along the skeletal muscle around the left upper 12 mm port site and right hydronephrosis. The patient was diagnosed with PSM and retroperitoneal recurrence. Despite chemotherapy, three years postoperatively, PSM widely spread from the left upper abdomen to the left thigh, eventually inducing opioid-resistant leg pain and subsequent walking difficulties. Palliative radiotherapy could not improve these symptoms. The patient died three years and five months postoperatively. Extensively invasive PSM can induce refractory cancer pain and physical disorders. Therefore, early detection and palliative resection of PSM may help maintain the quality of life of patients with gastric cancer.